My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody

Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody

Interleukin 6, IL-6, IL6, BSF2, HGF, HSF, IFNB2, BSF-2, CDF, IFN-beta-2, Interleukin 6 receptor, CD126, Cluster of Differentiation 126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80

Catalog No. Product Name Size List Price (US$) Quantity
C032P Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody 1 mg 175.00
C032P Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody 5 mg 600.00
C032P Tocilizumab Biosimilar, Human IL-6R Monoclonal Antibody 20 mg 1600.00
Description

C032P: Tocilizumab Biosimilar, IL-6R Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Isotype: Human IgG1 kappa.
Source: The anti-human IL-6R monoclonal antibody tocilizumab biosimilar was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade tocilizumab biosimilar specifically binds to the human interleukin-6 receptor (IL-6R).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tocilizumab.
Form of Antibody: 0.2 uM filtered solution, pH 6.5, no stabilizers or preservatives.
Endotoxin: <1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The research grade tocilizumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Background

What is tocilizumab biosimilar research grade? Tocilizumab biosimilar uses the same protein sequences as the therapeutic antibody tocilizumab. Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions. Interleukin 6 (IL-6) is a pro-inflammatory cytokine produced by cells including T-cells, B-cells, lymphocytes, monocytes, fibroblasts. IL-6 rapidly induces C-reactive protein, serum amyloid A, fibrinogen, haptoglobin, and α-1-antichymotrypsin while inhibiting production of fibronectin, albumin, and transferrin. IL-6 also induces antibody production, induces cytotoxic T-cell differentiation, and inhibits regulatory T-cell differentiation. Tocilizumab binds soluble and membrane bound IL-6 receptors, preventing IL-6 mediated inflammation.

Syd Labs also provides the following anti-IL antibody biosimilar proteins:
Pascolizumab Biosimilar, research grade, anti-human IL-4 monoclonal antibody
Sarilumab Biosimilar, research grade, anti-human IL-6/IL-6R monoclonal antibody
Secukinumab Biosimilar, research grade, anti-human IL-17/IL-17a monoclonal antibody
Briakinumab Biosimilar, research grade, anti-human IL-12/IL-23 monoclonal antibody
Ustekinumab Biosimilar, research grade, anti-human IL-12/IL-23 monoclonal antibody

Related Links

See our Privacy Policy